Elderly receive good protection with these two Covid-19 vaccines

  • Seniors
  • Sunday, 18 Apr 2021

An 86-year-old British woman gets a dose of the AstraZeneca/Oxford Covid-19 vaccine, which provides about 86% antibody protection five to six weeks after the first dose, as her 90-year-old husband looks on. — AFP

People aged over 80 receiving a single dose of either the Pfizer/BioNTech or AstraZeneca/Oxford Covid-19 vaccines show equivalent antibody responses five weeks post-vaccination.

However, stronger cellular (T cell) responses were seen in those who had received the AstraZeneca/Oxford vaccine.

Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

Next In Health

Five alternative therapies to help you quit smoking
Feel the kilos piling on after hitting menopause?
Is healthcare prepared for the advent of AI?
How much screen time is too much time for your kids?
Dealing with pain during your period
Is it a stroke or am I going to get a migraine?
Regrowing the skull bone with 3D printing technology
Stroke patients recommended to get genetic test to optimise treatment
Clearing the air on the tobacco generational endgame Bill
Health White Paper open for continuous feedback from public

Others Also Read